Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii

被引:13
|
作者
Lomovskaya, Olga [1 ,4 ]
Sun, Dongxu [1 ]
Rubio-Aparicio, Debora [1 ]
Nelson, Kirk J. [1 ]
Thamlikitkul, Visanu [2 ]
Dudley, Michael N. [1 ]
Redell, Mark A. [3 ]
机构
[1] The Med Co, 3013 Sci Pk Rd, San Diego, CA 92121 USA
[2] Mahidol Univ, Siriraj Hosp, Dept Med, Div Infect Dis & Trop Med,Fac Med, Bangkok 10700, Thailand
[3] Melinta Therapeut, 300 George St, New Haven, CT 06511 USA
[4] The Med Co, Infect Dis, Biol, 3013 Sci Pk Rd,1st Floor, San Diego, CA 92121 USA
关键词
Minocycline; Acinetobacter; Efflux; TetB; Tetracycline; Resistance; EFFLUX; RESISTANCE; COMPLEX; UPDATE; GENES;
D O I
10.1016/j.ijantimicag.2018.04.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Minocycline is one of the few options available to treat infections caused by Acinetobacter baumannii. Acquired resistance to minocycline in A. baumannii is associated with presence of the TetB efflux pump. Previous studies suggested that the absence of tetB may predict minocycline minimum inhibitory concentrations (MICs) of <= 4 mu g/mL. In this study, a collection of 258 A. baumannii isolates was used to generate MIC frequency distributions for the tetB-positive and -negative sets of isolates. Of the 93 tetB -negative strains, all had minocycline MICs <= 4 mu g/mL, resulting in a negative predictive value of 100%. Of the 165 tetB-positive strains, 154 had minocycline MICs > 4 mu g/mL, resulting in a positive predictive value of 93.3%. In conclusion, this study shows that tetB is highly associated with MICs above the current US Food and Drug Administration (FDA) and Clinical and Laboratory Standards Institute (CLSI) susceptible breakpoint of 4 mu g/mL. (c) 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:404 / 406
页数:3
相关论文
共 50 条
  • [21] CHARACTERISTICS OF ANTIBIOTIC SENSITIVITY OF ACINETOBACTER BAUMANNII bv. TRYPTOPHANDESTRUENS AND ACINETOBACTER BAUMANNII CLINICAL ISOLATES
    Sivolodskii, E. P.
    Kraeva, L. A.
    Melnicova, E. V.
    Gorelova, G. V.
    INFEKTSIYA I IMMUNITET, 2024, 14 (01): : 170 - 174
  • [22] Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii
    Mirian Marcolan De Mello
    Patrícia Pimentel De Barros
    Renata de Cassia Bernardes
    Silvio Rubens Alves
    Naiara Pires Ramanzini
    Lívia Mara Alves Figueiredo-Godoi
    Ana Carolina Chipoletti Prado
    Antonio Olavo Cardoso Jorge
    Juliana Campos Junqueira
    Lasers in Medical Science, 2019, 34 : 1755 - 1761
  • [23] Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii
    De Mello, Mirian Marcolan
    De Barros, Patricia Pimentel
    Bernardes, Renata de Cassia
    Alves, Silvio Rubens
    Ramanzini, Naiara Pires
    Alves Figueiredo-Godoi, Livia Mara
    Chipoletti Prado, Ana Carolina
    Cardoso Jorge, Antonio Olavo
    Junqueira, Juliana Campos
    LASERS IN MEDICAL SCIENCE, 2019, 34 (09) : 1755 - 1761
  • [24] In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy
    Mezzatesta M.L.
    Trovato G.
    Gona F.
    Nicolosi V.M.
    Nicolosi D.
    Carattoli A.
    Fadda G.
    Nicoletti G.
    Stefani S.
    Annals of Clinical Microbiology and Antimicrobials, 7 (1)
  • [25] Pharmacodynamics of minocycline against Acinetobacter baumannii studied in a pharmacokinetic model of infection
    Alfouzan, Wadha A.
    Noel, A. R.
    Bowker, Karen E.
    Attwood, M. L. G.
    Tomaselli, S. G.
    MacGowan, Alasdair P.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 (06) : 715 - 717
  • [26] Transcriptome Analysis of Acinetobacter baumannii in Rapid Response to Subinhibitory Concentration of Minocycline
    Gao, Lili
    Ma, Xiaochun
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)
  • [27] Phylogenomics of colistin-susceptible and resistant XDR Acinetobacter baumannii
    Mustapha, Mustapha M.
    Li, Bin
    Pacey, Marissa P.
    Mettus, Roberta T.
    McElheny, Christi L.
    Marshall, Christopher W.
    Ernst, Robert K.
    Cooper, Vaughn S.
    Doi, Yohei
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (11) : 2952 - 2959
  • [28] Prevalence of hypermutators among clinical Acinetobacter baumannii isolates
    Lindgren, Patricia Komp
    Higgins, Paul G.
    Seifert, Harald
    Cars, Otto
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) : 661 - 665
  • [29] Adherence and motility characteristics of clinical Acinetobacter baumannii isolates
    Eijkelkamp, Bart A.
    Stroeher, Uwe H.
    Hassan, Karl A.
    Papadimitrious, Michael S.
    Paulsen, Ian T.
    Brown, Melissa H.
    FEMS MICROBIOLOGY LETTERS, 2011, 323 (01) : 44 - 51
  • [30] Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates
    Aliakbarzade, Katayun
    Farajnia, Safar
    Nik, Ashraf Karimi
    Zarei, Farzaneh
    Tanomand, Asghar
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2014, 7 (10)